STI 021 Pill - blue capsule/oblong, 16mm
Pill with imprint STI 021 is Blue, Capsule/Oblong and has been identified as Cyclophosphamide 25 mg. It is supplied by STI Pharma LLC.
Cyclophosphamide is used in the treatment of Acute Lymphocytic Leukemia; Acute Nonlymphocytic Leukemia; Breast Cancer; Cancer; Chronic Lymphocytic Leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Cyclophosphamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for STI 021
Cyclophosphamide
- Imprint
- STI 021
- Strength
- 25 mg
- Color
- Blue
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- STI Pharma LLC
- National Drug Code (NDC)
- 54879-0021
- Inactive Ingredients
-
corn starch,
sodium stearyl fumarate,
FD&C Blue No. 1,
FD&C Red No. 3,
gelatin,
titanium dioxide,
ammonia,
ferrosoferric oxide,
isopropyl alcohol,
alcohol,
butyl alcohol,
propylene glycol,
shellac,
water
Note: Inactive ingredients may vary.
More about cyclophosphamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Patient resources
- Cyclophosphamide oral and injection drug information
- Cyclophosphamide (Advanced Reading)
- Cyclophosphamide Tablets
- Cyclophosphamide Capsules
Other brands
Cytoxan, Neosar, Cytoxan Lyophilized
Professional resources
- Cyclophosphamide monograph
- Cyclophosphamide (FDA)
- Cyclophosphamide Capsules (FDA)
- Cyclophosphamide Concentrate Injection (FDA)
- Cyclophosphamide Injection (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
